Mochida Pharmaceutical Co.,Ltd. [4534.T]
TOKYO, Mar 30 (Pulse News Wire) – Mochida Pharmaceutical CO.,LTD. (4534.T) announced plans to sell its ordinary shares through Mitsubishi UFJ Morgan Stanley Securities.
The offering involves up to 1,000,000 shares and will take place between May 18 and April 9, 2026, based on market conditions. The selling price will be determined on the final day within this range, calculated as 0.90 to 1.00 times the closing price of Mochida's ordinary shares on the Tokyo Stock Exchange on that day, rounded down to the nearest whole number. Additionally, the company resolved to repurchase up to 530,000 shares starting from May 18, 2026. Details of the share buyback can be found in a separate press release.
Separately, Mochida also outlined an over-allotment option mechanism, allowing Mitsubishi UFJ Morgan Stanley Securities to borrow up to 1,000,000 shares from shareholders for potential additional sales. The exercise period for the green shoe option runs until April 23, 2026. This equity sale aims to enhance liquidity and attract long-term strategic investors supportive of Mochida’s growth strategy. The company continues to focus on strengthening its core pharmaceutical business and expanding into biologics and generics to drive sustainable value creation.
🟢 Confidence: High AI-translated content.